Publications en collaboration avec des chercheurs de Swiss Federal Institute of Technology in Zurich (1)

2020

  1. CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo

    Journal of Clinical Investigation, Vol. 130, Núm. 5, pp. 2435-2450